See Pharmaceutical Market Healthy In 2010SeeNews - Research & ProfilesMarch 10, 2011 3 Pages - SKU: ALD6655675 |
| Countries covered: Europe The pharmaceutical market in Southeast Europe (SEE) continued to grow in 2010 despite the economic volatility brought on by the global financial crisis. Pharmaceutical sales in the region are still dominated by generic drugs, especially in terms of volume, due to low per capita income and underinvestment inresearch and development activities focused on new medicines. |
More Europe Prescription Drugs Reports
Pharmaceuticals – Poland – a snapshot (2011) by
Mintel - Snapshots
Pharmaceuticals in Poland by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...
Switzerland Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: The expected growth of the Switzerland’s ageing population over the next 50 years will havean unprecedented impact on the demand for healthcare. The ...
Spain Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: Companies with significant exposure to debt-ridden European markets will be hard hit bygovernment austerity measures across the region, particularly by pharmaceutical price erosionmechanisms. ...
Romania Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: Following the resignation of Emil Boc and his government in February 2012, there is nowconsiderable uncertainty with regard to reform of the Romanian ...
Portugal Pharmaceuticals and Healthcare Report Q2 2012 by
Business Monitor International
BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measureshave taken their toll on all sectors – including ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Related Markets
Prescription Drugs Reports
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program

